Conjunctival flora in patients with type 1 or type 2 diabetes mellitus

Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromi...

Full description

Saved in:
Bibliographic Details
Published inAdvances in therapy Vol. 24; no. 5; pp. 1028 - 1035
Main Authors Bilen, Habib, Ates, Orhan, Astam, Neslihan, Uslu, Hakan, Akcay, Gungor, Baykal, Orhan
Format Journal Article
LanguageEnglish
Published United States 01.09.2007
Subjects
Online AccessGet full text
ISSN0741-238X
1865-8652
DOI10.1007/BF02877708

Cover

Abstract Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.
AbstractList Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Clycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Cram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 1 7 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%).Staphylococcus epidermidis (11.79%) andStaphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and Sepidermidis (24.2%) and Saureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, Sepidermidis (22%), Saureus (12%), andCorynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of Saureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%--80%); gram-negative organisms (15%--29%) and fungi (3%--13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in Saureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, Sepidermidis and Saureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.
Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.
Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.
Author Bilen, Habib
Baykal, Orhan
Uslu, Hakan
Astam, Neslihan
Ates, Orhan
Akcay, Gungor
Author_xml – sequence: 1
  givenname: Habib
  surname: Bilen
  fullname: Bilen, Habib
– sequence: 2
  givenname: Orhan
  surname: Ates
  fullname: Ates, Orhan
– sequence: 3
  givenname: Neslihan
  surname: Astam
  fullname: Astam, Neslihan
– sequence: 4
  givenname: Hakan
  surname: Uslu
  fullname: Uslu, Hakan
– sequence: 5
  givenname: Gungor
  surname: Akcay
  fullname: Akcay, Gungor
– sequence: 6
  givenname: Orhan
  surname: Baykal
  fullname: Baykal, Orhan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18029329$$D View this record in MEDLINE/PubMed
BookMark eNqF0EtLxDAQB_AgivvQix9AcvIgVCdpm8dRF1eFBS8K3kraTjFLXzapst_eyK4siOBhmDn8Zhj-M3LYdi0ScsbgigHI69slcCWlBHVApkyJNArFD8kUZMIiHqvXCZk5twbgIFN1TCZMAdcx11OyXHTtemwLbz9MTau6Gwy1Le2Nt9h6Rz-tf6N-0yNltBu2E6elNTl6dLTBurZ-dCfkqDK1w9Ndn5OX5d3z4iFaPd0_Lm5WUREz4SPJqkRCKWKViLJKhJE8QV2YElPDuDbh11RDjpAGXkkMVKNGLIzIOdMmnpOL7d1-6N5HdD5rrCvCE6bFbnSZUGksQKf_Qs44A6XiAM93cMwbLLN-sI0ZNtlPRAFcbkExdM4NWO0JZN_5Z_v8A4ZfuLA-ZNm1fjC2_mvlC_QvhSU
CitedBy_id crossref_primary_10_1016_j_exer_2021_108455
crossref_primary_10_1038_s41598_021_81507_x
crossref_primary_10_3109_15569527_2012_692136
crossref_primary_10_1016_j_survophthal_2021_03_010
crossref_primary_10_1016_j_pcd_2017_05_009
crossref_primary_10_1016_j_visres_2017_03_002
crossref_primary_10_1016_j_biopha_2022_113530
crossref_primary_10_1038_eye_2013_103
crossref_primary_10_1097_ICU_0b013e32830d5da2
crossref_primary_10_3390_ijms22179641
crossref_primary_10_3389_fcimb_2019_00202
crossref_primary_10_1080_02713683_2017_1406528
crossref_primary_10_1186_s12866_024_03247_y
crossref_primary_10_1097_ICO_0000000000000909
crossref_primary_10_22141_2309_8147_9_1_2021_229518
crossref_primary_10_1016_j_jtos_2023_04_003
crossref_primary_10_1038_eye_2009_218
crossref_primary_10_1080_02713680902725970
crossref_primary_10_4103_2347_5617_150212
crossref_primary_10_1136_bmjdrc_2019_001094
crossref_primary_10_1177_2058739218793550
crossref_primary_10_1016_j_bios_2012_04_030
crossref_primary_10_1016_j_jdiacomp_2018_09_015
crossref_primary_10_1016_j_fshw_2013_09_002
crossref_primary_10_15406_aovs_2024_14_00457
crossref_primary_10_3341_kjo_2019_0144
crossref_primary_10_4103_ijo_IJO_1485_21
crossref_primary_10_3109_08820538_2016_1170165
crossref_primary_10_1016_j_jtos_2017_10_006
crossref_primary_10_1136_bjophthalmol_2018_312709
crossref_primary_10_5402_2012_456209
Cites_doi 10.1016/S0161-6420(13)31268-8
10.1016/S0891-5520(20)30648-6
10.1016/S0002-9394(14)76728-5
10.1001/archopht.1982.01030040253009
10.1111/j.1540-8191.2005.200472.x
10.1111/j.1755-3768.1975.tb01157.x
10.1016/S0008-4182(05)80004-3
10.1016/S0891-5520(20)30638-3
10.1016/0168-8227(93)90112-I
10.2337/diab.45.10.1289
10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
10.1136/bjo.80.8.681
10.1016/S0891-5520(20)30482-7
10.2337/diacare.10.4.483
10.2337/diabetes.38.8.1031
10.1016/S0002-9394(14)72773-4
10.1177/014860719802200277
10.1093/clinids/21.3.479
10.2337/diabetes.54.10.2904
10.2337/diacare.22.8.1354
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T7
8FD
C1K
FR3
M7N
P64
7X8
DOI 10.1007/BF02877708
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Technology Research Database
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1865-8652
EndPage 1035
ExternalDocumentID 18029329
10_1007_BF02877708
Genre Journal Article
GroupedDBID ---
-Y2
.86
.VR
06C
06D
0R~
0VY
1N0
23M
2J2
2JY
2KG
2KM
2VQ
30V
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
8TC
95-
95.
95~
96X
AABHQ
AACDK
AAIAL
AAIKX
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABFSG
ABFTV
ABHLI
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABPLI
ABQBU
ABTKH
ABTMW
ABXPI
ACAOD
ACCOQ
ACDTI
ACGFS
ACHXU
ACKNC
ACMLO
ACOKC
ACPIV
ACSNA
ACSTC
ACZOJ
ADHHG
ADHIR
ADKPE
ADRFC
ADURQ
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFLOW
AFOHR
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AIXLP
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
ARMRJ
ATHPR
AWSVR
AXYYD
AYFIA
B-.
BA0
BGNMA
CAG
CITATION
COF
CS3
CSCUP
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FERAY
FFXSO
FIGPU
FLLZZ
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGRSB
GJIRD
GNWQR
GQ7
H13
HF~
HG5
HG6
HMJXF
HRMNR
HZ~
IWAJR
IXC
IXD
I~X
I~Z
J-C
JBSCW
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
MK0
NQJWS
NU0
O9-
O93
O9I
OVD
P2P
P9S
PF0
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNPRN
SNX
SOHCF
SOJ
SPKJE
SRMVM
SSLCW
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TT1
TUC
U2A
U9L
UG4
UTJUX
UZXMN
VC2
VDBLX
VFIZW
W48
WK8
Z45
ZMTXR
~A9
~JE
2JN
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T7
8FD
ABRTQ
C1K
FR3
M7N
P64
7X8
ID FETCH-LOGICAL-c316t-71f470d63846df46a724e9cade5a129a238590be05316f7e0d69e9eeca6b219a3
ISSN 0741-238X
IngestDate Thu Sep 04 23:13:49 EDT 2025
Thu Sep 04 17:51:52 EDT 2025
Thu Apr 03 07:06:43 EDT 2025
Tue Jul 01 01:21:31 EDT 2025
Thu Apr 24 23:03:03 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://www.springer.com/tdm
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c316t-71f470d63846df46a724e9cade5a129a238590be05316f7e0d69e9eeca6b219a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18029329
PQID 21210883
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_68536095
proquest_miscellaneous_21210883
pubmed_primary_18029329
crossref_primary_10_1007_BF02877708
crossref_citationtrail_10_1007_BF02877708
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-09-01
PublicationDateYYYYMMDD 2007-09-01
PublicationDate_xml – month: 09
  year: 2007
  text: 2007-09-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Advances in therapy
PublicationTitleAlternate Adv Ther
PublicationYear 2007
References BM Desai (BF02877708_CR2) 1987; 35
J Rich (BF02877708_CR3) 2005; 54
M Delamaire (BF02877708_CR10) 1997; 14
U Seifart (BF02877708_CR4) 1994; 91
JB Dickey (BF02877708_CR22) 1991; 112
BF02877708_CR1
C Ramos-Remus (BF02877708_CR5) 1994; 12
JD Breen (BF02877708_CR17) 1995; 9
WB Philips (BF02877708_CR21) 1994; 101
CT Moeller (BF02877708_CR7) 2005; 40
LA Hruska (BF02877708_CR13) 2005; 20
AN Syed (BF02877708_CR15) 1992; 6
MR Tierney (BF02877708_CR20) 1995; 9
W Marhoffer (BF02877708_CR8) 1993; 19
JJ Pomposelli (BF02877708_CR12) 1998; 22
CP Nielson (BF02877708_CR9) 1989; 38
J Baum (BF02877708_CR25) 1995; 21
SD Januss (BF02877708_CR23) 1996; 80
BA Lipsky (BF02877708_CR18) 1987; 10
RO Schultz (BF02877708_CR19) 1983; 81
MS Osato (BF02877708_CR6) 1996
The Diabetes Control and Complications Trial Research Group (BF02877708_CR11) 1996; 45
S Stenson (BF02877708_CR16) 1982; 100
JA Fahmi (BF02877708_CR14) 1975; 53
L Apt (BF02877708_CR24) 1994; 119
References_xml – volume: 101
  start-page: 508
  year: 1994
  ident: BF02877708_CR21
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(13)31268-8
– volume: 9
  start-page: 195
  year: 1995
  ident: BF02877708_CR20
  publication-title: Infect Dis Clin North Am.
  doi: 10.1016/S0891-5520(20)30648-6
– volume: 112
  start-page: 278
  year: 1991
  ident: BF02877708_CR22
  publication-title: Am J Ophthalmol.
  doi: 10.1016/S0002-9394(14)76728-5
– volume: 100
  start-page: 1275
  year: 1982
  ident: BF02877708_CR16
  publication-title: Arch Ophthalmol.
  doi: 10.1001/archopht.1982.01030040253009
– volume: 20
  start-page: 403
  year: 2005
  ident: BF02877708_CR13
  publication-title: J Card Surg.
  doi: 10.1111/j.1540-8191.2005.200472.x
– volume: 91
  start-page: 235
  year: 1994
  ident: BF02877708_CR4
  publication-title: Ophthalmologe
– volume: 53
  start-page: 237
  year: 1975
  ident: BF02877708_CR14
  publication-title: Acta Ophthalmol.
  doi: 10.1111/j.1755-3768.1975.tb01157.x
– volume: 40
  start-page: 448
  year: 2005
  ident: BF02877708_CR7
  publication-title: Can J Ophthalmol.
  doi: 10.1016/S0008-4182(05)80004-3
– volume: 9
  start-page: 11
  year: 1995
  ident: BF02877708_CR17
  publication-title: Infect Dis Clin North Am.
  doi: 10.1016/S0891-5520(20)30638-3
– volume: 19
  start-page: 183
  year: 1993
  ident: BF02877708_CR8
  publication-title: Diabetes Res Clin Pract.
  doi: 10.1016/0168-8227(93)90112-I
– volume: 45
  start-page: 1289
  year: 1996
  ident: BF02877708_CR11
  publication-title: Diabetes
  doi: 10.2337/diab.45.10.1289
– volume: 14
  start-page: 29
  year: 1997
  ident: BF02877708_CR10
  publication-title: Diabet Med.
  doi: 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
– volume: 80
  start-page: 681
  year: 1996
  ident: BF02877708_CR23
  publication-title: Br J Ophthalmol.
  doi: 10.1136/bjo.80.8.681
– start-page: 191
  volume-title: Ocular Infection and Immunity
  year: 1996
  ident: BF02877708_CR6
– volume: 6
  start-page: 789
  year: 1992
  ident: BF02877708_CR15
  publication-title: Infect Dis Clin North Am.
  doi: 10.1016/S0891-5520(20)30482-7
– volume: 10
  start-page: 483
  year: 1987
  ident: BF02877708_CR18
  publication-title: Diabetes Care.
  doi: 10.2337/diacare.10.4.483
– volume: 38
  start-page: 1031
  year: 1989
  ident: BF02877708_CR9
  publication-title: Diabetes
  doi: 10.2337/diabetes.38.8.1031
– volume: 119
  start-page: 701
  year: 1994
  ident: BF02877708_CR24
  publication-title: Am J Ophthalmol.
  doi: 10.1016/S0002-9394(14)72773-4
– volume: 35
  start-page: 130
  year: 1987
  ident: BF02877708_CR2
  publication-title: Indian J Ophthalmol.
– volume: 22
  start-page: 77
  year: 1998
  ident: BF02877708_CR12
  publication-title: J Patenter Enterai Nutr.
  doi: 10.1177/014860719802200277
– volume: 81
  start-page: 107
  year: 1983
  ident: BF02877708_CR19
  publication-title: Trans Am Ophthalmol Soc.
– volume: 21
  start-page: 475
  year: 1995
  ident: BF02877708_CR25
  publication-title: Clin Infect Dis.
  doi: 10.1093/clinids/21.3.479
– volume: 54
  start-page: 2904
  year: 2005
  ident: BF02877708_CR3
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.10.2904
– volume: 12
  start-page: 375
  year: 1994
  ident: BF02877708_CR5
  publication-title: Clin Exp Rheumatol.
– ident: BF02877708_CR1
  doi: 10.2337/diacare.22.8.1354
SSID ssj0020758
Score 1.9430015
Snippet Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms....
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1028
SubjectTerms Conjunctiva - microbiology
Diabetes Mellitus, Type 1 - microbiology
Diabetes Mellitus, Type 2 - microbiology
Glycated Hemoglobin A - analysis
Humans
Lacrimal Apparatus - microbiology
Title Conjunctival flora in patients with type 1 or type 2 diabetes mellitus
URI https://www.ncbi.nlm.nih.gov/pubmed/18029329
https://www.proquest.com/docview/21210883
https://www.proquest.com/docview/68536095
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdb-7KX0X1nn4KNwmg9_CHL8mNSGsLo0j44kDcjOTLtljkldh66v353kWU5W8s-HmyMLGSj-3F3ku5-R8iHSKVxqiVG9y-Ux1RUeIrx0FOBUkLEHF7jfseXKZ_M2Od5PHdVOrfZJY36VPy4Na_kf6QKbSBXzJL9B8l2g0IDPIN84Q4ShvtfyfhkVX0Fu4QVypZHJay85ZGjSq17e6wBhp3_utv6Hbk4m3bhb4loTUhA3YY_9gkHRqA_tipqItWV6oDSGD1zvr50OBuCy2lwpsGN7b2Y1cuNGeJb22g3HJIuosrqJXBCPLD0c2NCjN4UPPbg2lGsJjm6BVDc05Lo1PQsbuAbxpLftLlvY9RDZC30hbNZ9px-ep6PZ2dneXY6z-6T_TBJ8Kx-fzgejabduhu8ImHYWM1_77LUtmPv-iV3LDa2Tkd2QB62qwU6NKJ_RO7p6jE5vDB04zfHNHPZc_UxPaQXjoj85gkZ9_FBt_igVxW1-KCID4qooAFdrc1TSC0-qMXHUzIbn2YnE6-tm-EVUcAbLwlKlvgL0KyML0rGZRIynWK6RSzBvZMwB3HqKywKEvAy0dA11anWheQKDJiMnpG9alXpF4QWRSo4L7VIkEaICalYiBVq4kXJQZuzAfloZy0vWlJ5rG2yzC0dtpvhAXnf9b02VCq39npnJz8HTYfHV7LSq02dh8h1J0R0dw8OvicSKA7IcyM19x3hg18bpi__OPor8sCB_jXZa9Yb_Qb8zka9bXH1E5nHgig
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conjunctival+flora+in+patients+with+type+1+or+type+2+diabetes+mellitus&rft.jtitle=Advances+in+therapy&rft.au=Bilen%2C+Habib&rft.au=Ates%2C+Orhan&rft.au=Astam%2C+Neslihan&rft.au=Uslu%2C+Hakan&rft.date=2007-09-01&rft.issn=0741-238X&rft.eissn=1865-8652&rft.volume=24&rft.issue=5&rft.spage=1028&rft.epage=1035&rft_id=info:doi/10.1007%2FBF02877708&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-238X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-238X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-238X&client=summon